80 FR 16 pgs. 3984-3985 - Manufacturer of Controlled Substances Registration: Mallinckrodt, LLC
Type: NOTICEVolume: 80Number: 16Pages: 3984 - 3985
Pages: 3984, 3985Docket number: [Docket No. DEA-392]
FR document: [FR Doc. 2015-01304 Filed 1-23-15; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Manufacturer of Controlled Substances Registration: Mallinckrodt, LLC
ACTION:
Notice of registration.
SUMMARY:
Mallinckrodt, LLC applied to be registered as a manufacturer of certain basic classes of controlled substances. The DEA grants Mallinckrodt, LLC registration as a manufacturer of those controlled substances.
SUPPLEMENTARY INFORMATION:
By notice dated May 28, 2014, and published in the Federal Register on June 3, 2014, 79 FR 31986, Mallinckrodt, LLC, 3600 North Second Street, St. Louis, Missouri 63147, applied to be registered as a manufacturer of certain basic classes of controlled substances. No comments or objections were submitted to this notice.
The Drug Enforcement Administration (DEA) has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Mallinckrodt, LLC to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of the basic classes of controlled substances:
[top]
| Controlled substance | Schedule |
|---|---|
| Tetrahydrocannabinols (7370) | I |
| Codeine-N-oxide (9053) | I |
| Dihydromorphine (9145) | I |
| Difenoxin (9168) | I |
| Morphine-N-oxide (9307) | I |
| Normorphine (9313) | I |
| Norlevorphanol (9634) | I |
| Amphetamine (1100) | II |
| Methamphetamine (1105) | II |
| Methylphenidate (1724) | II |
| Nabilone (7379) | II |
| 4-Anilino-N-phenethyl-4-piperidine (8333) | II |
| Codeine (9050) | II |
| Dihydrocodeine (9120) | II |
| Oxycodone (9143) | II |
| Hydromorphone (9150) | II |
| Diphenoxylate (9170) | II |
| Ecgonine (9180) | II |
| Hydrocodone (9193) | II |
| Levorphanol (9220) | II |
| Meperidine (9230) | II |
| Methadone (9250) | II |
| Methadone intermediate (9254) | II |
| Dextropropoxyphene, bulk (non-dosage forms) (9273) | II |
| Morphine (9300) | II |
| Thebaine (9333) | II |
| Opium tincture (9630) | II |
| Opium, powdered (9639) | II |
| Oxymorphone (9652) | II |
| Noroxymorphone (9668) | II |
| Alfentanil (9737) | II |
| Remifentanil (9739) | II |
| Sufentanil (9740) | II |
| Fentanyl (9801) | II |
The company plans to manufacture the listed controlled substances for internal use and for distribution to other companies.
Dated: January 9, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-01304 Filed 1-23-15; 8:45 am]
BILLING CODE 4410-09-P